01 / Vendor Profile
INTEGRATED DNA TECHNOLOGIES, INC. Federal Contracts and Awards
UEI P55FTN1UMYZ1 · CAGE 1V0C1
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $7.71M in net contract obligations to INTEGRATED DNA TECHNOLOGIES, INC. across 155 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
INTEGRATED DNA TECHNOLOGIES, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$328.2K
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $2.12M | 36 | 6 | — |
| FY 2021 | $2.50M | 20 | 5 | +18.0% |
| FY 2022 | $2.39M | 30 | 6 | −4.3% |
| FY 2023 | $1.37M | 19 | 3 | −42.7% |
| FY 2024 | -$1.29M | 29 | 7 | −193.8% |
| FY 2025 | $280.5K | 14 | 4 | +121.8% |
| FY 2026 | $328.2K | 7 | 6 | +17.0% |
04 / Federal Customers
Which federal agencies buy from INTEGRATED DNA TECHNOLOGIES, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7523 | $4.23M | 52 | 54.9% | |
| 7529 | $1.88M | 68 | 24.3% | |
| 2100 | $689.0K | 4 | 8.9% | |
| 97DH | $447.5K | 8 | 5.8% | |
| 1700 | $296.5K | 10 | 3.8% | |
| 1330 | $57.1K | 5 | 0.7% | |
| 12H2 | $56.6K | 2 | 0.7% | |
| 1448 | $38.4K | 3 | 0.5% | |
| 8000 | $8.5K | 1 | 0.1% | |
| 7524 | $8.4K | 2 | 0.1% |
05 / Contracting Offices
Which contracting offices buy from INTEGRATED DNA TECHNOLOGIES, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $4.23M | 52 | 54.9% | |
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $1.07M | 9 | 13.9% | |
| W81XWH | DEPT OF THE ARMY | $689.0K | 4 | 8.9% | |
| HT9425 | DEFENSE HEALTH AGENCY (DHA) | $309.1K | 5 | 4.0% | |
| N00173 | DEPT OF THE NAVY | $296.5K | 6 | 3.8% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $272.3K | 7 | 3.5% | |
| 75N92E | NATIONAL INSTITUTES OF HEALTH | $189.1K | 13 | 2.5% | |
| HT9427 | DEFENSE HEALTH AGENCY (DHA) | $103.0K | 1 | 1.3% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $98.8K | 9 | 1.3% | |
| 75N980 | NATIONAL INSTITUTES OF HEALTH | $77.1K | 1 | 1.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325199 | ALL OTHER BASIC ORGANIC CHEMICAL MANUFACTURING | $3.85M | 71 | 6 | 49.9% |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | $1.83M | 41 | 5 | 23.7% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $1.08M | 13 | 2 | 14.0% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $653.8K | 12 | 6 | 8.5% |
| 541380 | TESTING LABORATORIES AND SERVICES | $277.4K | 9 | 3 | 3.6% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $24.2K | 2 | 2 | 0.3% |
| 541713 | RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY | $0 | 4 | 1 | 0.0% |
| 424210 | DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS | -$45 | 2 | 1 | 0.0% |
| 541710 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES | -$126 | 1 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $3.54M | 50 | 8 | 45.9% |
| 6505 | DRUGS AND BIOLOGICALS | $1.96M | 42 | 2 | 25.4% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1.39M | 24 | 6 | 18.0% |
| R702 | SUPPORT- MANAGEMENT: DATA COLLECTION | $670.4K | 2 | 1 | 8.7% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $113.0K | 4 | 3 | 1.5% |
| Q301 | MEDICAL- LABORATORY TESTING | $91.1K | 11 | 2 | 1.2% |
| B504 | SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | $46.7K | 4 | 1 | 0.6% |
| 5680 | MISCELLANEOUS CONSTRUCTION MATERIALS | $22.6K | 1 | 1 | 0.3% |
| B529 | SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | $15.7K | 1 | 1 | 0.2% |
| 6810 | CHEMICALS | $15.2K | 3 | 2 | 0.2% |
08 / Competition Pattern
How was INTEGRATED DNA TECHNOLOGIES, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for INTEGRATED DNA TECHNOLOGIES, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75F40126P00288 | Sep 14, 2026 | $24.0K | FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS | 541380 | Q301 |
10 / Interpreting the Profile
How should you evaluate INTEGRATED DNA TECHNOLOGIES, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.